[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"patents-list":3},{"list":4,"total":67,"page":68,"pageSize":69,"totalPages":68},[5,25,37,49,58],{"id":6,"patentNo":7,"title":8,"applicant":9,"inventors":10,"abstract":11,"ipc":12,"publishDate":13,"sourceUrl":13,"achievementId":13,"createdAt":14,"isOpenLicense":15,"licenseTerm":13,"licenseScope":13,"licenseFeeText":13,"licenseFeeNum":13,"patentType":16,"legalStatus":17,"applicationNo":7,"publicationNo":13,"mainIpc":18,"agency":13,"agent":13,"publishOrg":13,"provinceCode":13,"filingDate":13,"isRevitalized":19,"maintainYears":13,"isFunded":13,"implStatus1":13,"implStatus2":13,"willingness1":13,"willingness2":13,"feeWan":13,"intendedCity":13,"intendedCompany":13,"intendedPrice":13,"techMaturity":13,"starRating":13,"gbIndustryClass":13,"strategicClass":13,"productAdv":13,"prospect":13,"comboName":13,"batch":20,"province":21,"sourceText":22,"tags":23,"tagNames":24},"gpi_01041","CN200910302172.3","金钗石斛生物总碱在制备治疗糖尿病的药物中的应用及产品","遵义医学院","石京山","本发明公开了金钗石斛生物总碱在制备治疗糖尿病的药物中的应用及产品，所述的金钗石斛生物总碱是从金钗石斛中提取的亲脂性总生物碱类成分。与现有技术相比，本发明通过研究金钗石斛生物总碱对肾上腺素所致小鼠血糖升高模型和高糖高脂加链脲佐菌素诱导糖尿病大鼠模型的影响，进一步明确了其治疗糖尿病的药理作用和机制，为金钗石斛药材的开发应用提供了药理学依据。","A61K36\u002F8984;A61P3\u002F10;A61K135\u002F00",null,"2026-10-12T00:54:35.109Z",false,"发明专利","2010.02.24#公开;2010.06.30#实质审查的生效;2012.05.23#授权","A61K36\u002F8984",true,"gpi5份","520000;贵州省","粤港澳知识产权大数据综合服务平台(www.gpic.gd.cn)·广东省知识产权保护中心",[],[],{"id":26,"patentNo":27,"title":28,"applicant":29,"inventors":30,"abstract":31,"ipc":32,"publishDate":13,"sourceUrl":13,"achievementId":13,"createdAt":14,"isOpenLicense":15,"licenseTerm":13,"licenseScope":13,"licenseFeeText":13,"licenseFeeNum":13,"patentType":16,"legalStatus":33,"applicationNo":27,"publicationNo":13,"mainIpc":34,"agency":13,"agent":13,"publishOrg":13,"provinceCode":13,"filingDate":13,"isRevitalized":19,"maintainYears":13,"isFunded":13,"implStatus1":13,"implStatus2":13,"willingness1":13,"willingness2":13,"feeWan":13,"intendedCity":13,"intendedCompany":13,"intendedPrice":13,"techMaturity":13,"starRating":13,"gbIndustryClass":13,"strategicClass":13,"productAdv":13,"prospect":13,"comboName":13,"batch":20,"province":21,"sourceText":22,"tags":35,"tagNames":36},"gpi_00639","CN200910102408.9","5，6，7－三烷氧基－N－芳基取代－4－氨基喹唑啉类衍生物的制备方法及由此方法合成的化合物","贵州大学","杨松;胡德禹;张英;金林红;李宁;薛伟;宋宝安","本发明一种5，6，7－三烷氧基－N－芳基取代－4－氨基喹唑啉类衍生物的制备方法及由此方法合成的化合物，公开了以2，3，4－三烷氧基苯甲酸、硝酸、甲醇、硫酸、铁粉、氯化铵、钠、甲酰胺、三氯氧磷、三乙胺和芳香胺为原料，以甲醇，乙醇、异丙醇、N，N－二甲基甲酰胺和甲苯为溶剂，经六步合成，本发明是在4－苯胺基喹唑啉类衍生物的基础上，引入不同活性的基团而制备的一系列新型5，6，7－三烷氧基－N－芳基取代－4－氨基喹唑啉类化合物，这些化合物，具有较好的抑制蛋白磷酸化作用，具有较好的预防和治疗恶性肿瘤药物的前景，摘要附图为本发明化合物对前列腺癌细胞PC3蛋白磷酸化的影响试验结果之一。","C07D239\u002F94;A61K31\u002F517;A61P35\u002F00","2009.06.24#公开;2009.08.19#实质审查的生效;2010.12.08#授权","C07D239\u002F94",[],[],{"id":38,"patentNo":39,"title":40,"applicant":41,"inventors":42,"abstract":43,"ipc":44,"publishDate":13,"sourceUrl":13,"achievementId":13,"createdAt":14,"isOpenLicense":15,"licenseTerm":13,"licenseScope":13,"licenseFeeText":13,"licenseFeeNum":13,"patentType":16,"legalStatus":45,"applicationNo":39,"publicationNo":13,"mainIpc":46,"agency":13,"agent":13,"publishOrg":13,"provinceCode":13,"filingDate":13,"isRevitalized":19,"maintainYears":13,"isFunded":13,"implStatus1":13,"implStatus2":13,"willingness1":13,"willingness2":13,"feeWan":13,"intendedCity":13,"intendedCompany":13,"intendedPrice":13,"techMaturity":13,"starRating":13,"gbIndustryClass":13,"strategicClass":13,"productAdv":13,"prospect":13,"comboName":13,"batch":20,"province":21,"sourceText":22,"tags":47,"tagNames":48},"gpi_00003","CN200610201016.4","N－(N－苯甲酰基－苯丙氨酰基)－苯丙氨酸二肽衍生物及其制备方法和用途","贵州省中国科学院天然产物化学重点实验室;天津药物研究院;中国人民解放军第三○二医院","梁光义;徐必学;刘昌孝;黄正明;曹佩雪;蔡泽贵;刘玉明","本发明涉及通式(I)所示的N－(N－苯甲酰基－苯丙氨酰基)－苯丙氨酸二肽衍生物及其制备方法和用途，包括其消旋体或光学异构体及其药学上可接受的盐或水合物以及其与一种或多种药学上可接受的载体、赋形剂或稀释剂组成药物组合物；结构通式(I)的化合物具有抑制乙肝病毒(HBV)的活性，且较少出现其它毒副作用，是一类非核苷类抗病毒药，可用于制备治疗病毒性感染药物，尤其是用于制备抗乙肝病毒和抗人免疫缺陷病毒药物。","C07C237\u002F20;C07C237\u002F22;A61K31\u002F165;A61K31\u002F223;A61P31\u002F12;A61P1\u002F16","2007.03.28#公开;2007.05.23#实质审查的生效;2009.04.22#授权","C07C237\u002F20",[],[],{"id":50,"patentNo":51,"title":52,"applicant":9,"inventors":10,"abstract":53,"ipc":54,"publishDate":13,"sourceUrl":13,"achievementId":13,"createdAt":14,"isOpenLicense":15,"licenseTerm":13,"licenseScope":13,"licenseFeeText":13,"licenseFeeNum":13,"patentType":16,"legalStatus":55,"applicationNo":51,"publicationNo":13,"mainIpc":18,"agency":13,"agent":13,"publishOrg":13,"provinceCode":13,"filingDate":13,"isRevitalized":19,"maintainYears":13,"isFunded":13,"implStatus1":13,"implStatus2":13,"willingness1":13,"willingness2":13,"feeWan":13,"intendedCity":13,"intendedCompany":13,"intendedPrice":13,"techMaturity":13,"starRating":13,"gbIndustryClass":13,"strategicClass":13,"productAdv":13,"prospect":13,"comboName":13,"batch":20,"province":21,"sourceText":22,"tags":56,"tagNames":57},"gpi_00793","CN200910301762.4","金钗石斛生物总碱在制备治疗老年痴呆的药物中的应用及产品","本发明公开了金钗石斛生物总碱在制备治疗老年痴呆的药物中的应用及产品，所述的金钗石斛生物总碱是从金钗石斛中提取的亲脂性总生物碱类成分。与现有技术相比，本发明通过研究金钗石斛生物总碱对神经细胞、脑缺血模型的保护作用及对痴呆大鼠学习记忆能力的影响，明确了其治疗老年痴呆的药理作用和作用机制，为金钗石斛药材的开发应用提供了药理学依据。","A61K36\u002F8984;A61P25\u002F28","2009.09.23#公开;2010.06.30#实质审查的生效;2012.05.23#授权",[],[],{"id":59,"patentNo":60,"title":61,"applicant":9,"inventors":10,"abstract":62,"ipc":63,"publishDate":13,"sourceUrl":13,"achievementId":13,"createdAt":14,"isOpenLicense":15,"licenseTerm":13,"licenseScope":13,"licenseFeeText":13,"licenseFeeNum":13,"patentType":16,"legalStatus":64,"applicationNo":60,"publicationNo":13,"mainIpc":18,"agency":13,"agent":13,"publishOrg":13,"provinceCode":13,"filingDate":13,"isRevitalized":19,"maintainYears":13,"isFunded":13,"implStatus1":13,"implStatus2":13,"willingness1":13,"willingness2":13,"feeWan":13,"intendedCity":13,"intendedCompany":13,"intendedPrice":13,"techMaturity":13,"starRating":13,"gbIndustryClass":13,"strategicClass":13,"productAdv":13,"prospect":13,"comboName":13,"batch":20,"province":21,"sourceText":22,"tags":65,"tagNames":66},"gpi_00794","CN200910301763.9","金钗石斛生物总碱在制备治疗缺血性脑损伤的药物中的应用及产品","本发明公开了金钗石斛生物总碱在制备治疗缺血性脑损伤的药物中的应用及产品，所述的金钗石斛生物总碱是从金钗石斛中提取的亲脂性总生物碱类成分。与现有技术相比，本发明针对脑卒中的发病机制，通过研究金钗石斛生物总碱对原代皮层神经元缺氧缺糖损伤模型的保护作用及对大鼠急性脑缺血模型的保护作用，并分析其机制，进一步明确了其治疗脑缺血的药理作用和机制，为金钗石斛药材的开发应用提供了药理学依据。","A61K36\u002F8984;A61P9\u002F10;A61P25\u002F00;A61K135\u002F00","2009.09.23#公开;2010.06.30#实质审查的生效;2012.08.29#授权",[],[],5,1,30]